Post Resch Tallon Group Inc. Codexis, Inc. Transaction History
Post Resch Tallon Group Inc.
- $118 Billion
- Q4 2025
A detailed history of Post Resch Tallon Group Inc. transactions in Codexis, Inc. stock. As of the latest transaction made, Post Resch Tallon Group Inc. holds 511,748 shares of CDXS stock, worth $844,384. This represents 0.7% of its overall portfolio holdings.
Number of Shares
511,748
Previous 559,935
8.61%
Holding current value
$844,384
Previous $1.37 Billion
38.95%
% of portfolio
0.7%
Previous 1.21%
Shares
5 transactions
Others Institutions Holding CDXS
# of Institutions
144Shares Held
68.7MCall Options Held
42KPut Options Held
31.8K-
Opaleye Management Inc. Boston, MA12.8MShares$21.1 Million5.2% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$11.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.67MShares$7.71 Million0.0% of portfolio
-
Abrdn PLC4.09MShares$6.75 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.07MShares$6.71 Million0.0% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $108M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...